At Ajanta Pharma USA, our foremost responsibility is customer satisfaction through quality, supply, and customer service.
Never a team to rest on our success, we believe in constant, incremental, proactive improvement to our product and service standards can only be achieved by upgrading our technology, improving our training process, and embracing state-of-the-art manufacturing practices.
Each member of our US team and global workforce is responsible for the quality of his/her work and continuously strives to attain excellence. We treat each other fairly, with trust and respect, valuing involvement, open communication, and teamwork, so that we can foster that environment for our customers as well.
While the parent Ajanta Pharma Ltd. operates six finished dose manufacturing facilities in India, all products for the US are produced at the FDA-approved facilities at Aurangabad and Dahej, India.
Our Aurangabad location is the flagship finished oral solid dosage facility and also holds approvals by the World Health Organization and other global regulatory agencies.
The Dahej facility also focuses on oral solid dosage forms, employing the latest state-of-the-art manufacturing, packaging, and quality equipment and procedures.
To ensure adequate capacities to cater to the US market, Ajanta is proactively investing in additional facilities and manufacturing capabilities, to keep pace with our ever-increasing US portfolio.